Follow


Submissions from 2023

Link

CO125 Efficacy of Clascoterone Cream 1% for up to 12 Months in Patients ≥9 Years of Age with Acne vulgaris: Results from a Long-Term Extension Study, Lawrence F. Eichenfield, Adeaide A. Hebert, Linda F. Stein Gold, Martina Cartwright, L. Moro, J. Han, Nicholas Squittieri, and A. Mazzetti

Link

Efficacy and Safety of Clascoterone Cream 1% in Patients with Acne vulgaris across Subgroups Defined By Demographic Characteristics, Lawrence F. Eichenfield, Adelaide A. Hebert, Linda F. Stein Gold, Martina Cartwright, L. Moro, J. Han, Nicholas Squittieri, and A. Mazzetti

Link

Impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among patients with moderateto- severe non-nodular acne vulgaris (AV) administered sarecycline in real-world community practices across the US (PROSES Study), Richard G. Fried, Evan A. Rieder, Andrew F. Alexis, Hilary Baldwin, Emmy Graber, Julie C. Harper, Linda F. Stein Gold, Adelaide Hebert, James Del Rosso, Leon Kircik, Ayman Grada, Siva Narayanan, Volker Koscielny, and Ismail Kasujee

Link

Evaluation of an SPF50 sunscreen containing photolyase and antioxidants for its antiphotoaging properties, Jessica Kern, Emily Wood, Rawaa Almukhtar, Kunal Angra, Michael Lipp, and Mitchel Goldman

Link

PCR234 Impact of Draining Tunnels on Patient- and Physician-Reported Burden in Patients with Hidradenitis Suppurativa (HS), J. Kirby, Iltefat Hamzavi, A. P. Villani, R. B. Warren, A. Keal, A. C. Hernandez-Daly, R. Jha, H. Song, and A. B. Kimball

Link

Durability of efficacy and safety of roflumilast cream 0.3% in adults with chronic plaque psoriasis from a 52-Week, Phase 2 open-label safety trial, M. Lebwohl, Linda F. Stein Gold, M. J. Gooderham, K. A. Papp, L. K. Ferris, D. N. Adam, H. C. Hong, L. H. Kircik, M. Zirwas, P. Burnett, R. Higham, D. Krupa, and D. Berk

Link

533 Mpox first skin lesion location: A reflection of mode of transmission?, J. E. Lubov, A. G. Strahan, S. Prasad, C. G. Casas, G. Hruza, Henry W. Lim, L. E. French, and E. Freeman

Link

Comparison of investigator global assessment (IGA) and patient's global assessment (ptGA) of acne vulgaris among patients with moderate-to-severe non-nodular acne vulgaris (AV) administered sarecycline in community practices across the US: Analysis of PROSES study results, Linda F. Stein Gold, Andrew F. Alexis, Julie C. Harper, Emmy Graber, Hilary Baldwin, Leon Kircik, James Del Rosso, Richard G. Fried, Evan A. Rieder, Adelaide Hebert, Siva Narayanan, Volker Koscielny, and Ismail Kasujee

Link

Tapinarof cream 1% once daily for plaque psoriasis: improvements in quality of life and clinical efficacy in two pivotal Phase 3 trials, Linda F. Stein Gold, Christopher E. M Griffiths, Anna M. Tallman, Philip M. Brown, and Mark G. Lebwohl

Link

Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: Randomized Phase 2 and Phase 3 studies of the first triple combination drug, Linda F. Stein Gold, Leon H. Kircik, Emil A. Tanghetti, Hilary Baldwin, Zoe D. Draelos, Michael Gold, Edward Lain, David M. Pariser, Neil Sadick, Radhakrishnan Pillai, and Varsha Bhatt

Link

441 Mpox in persons living with HIV: Results from an international dermatologic registry, A. G. Strahan, J. E. Lubov, S. Prasad, C. G. Casas, G. Hruza, Henry W. Lim, L. E. French, and E. Freeman

Link

Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes re-pigmentation of stable lesions in patients with active nonsegmental vitiligo: results from a phase 2b, randomized, placebocontrolled, dose-ranging study, Yuji Yamaguchi, Elena Peeva, Ronald Shore, George Han, Lori A. Cox, Anindita Banerjee, Diamant Thaci, Iltefat Hamzavi, Abigail Sloan, Anand K. Ganesan, and Khaled Ezzedine

Submissions from 2022

PDF

34631 Do patients with vitiligo and health care professionals treating them recognize the burden in living with the disease in the United States? Findings from the VALIANT study, Kristen Bibeau, John E. Harris, Iltefat H. Hamzavi, Anouk Lindley, Christine LaFiura, and Khaled Ezzedine

PDF

Clinical Outcomes Associated With Melanocytic Lesions Assessed Via Ancillary Gene Expression Profiling (GEP), Wyatt Boothby-Shoemaker, Brittani Jones, Linna L. Guan, and Ben J. Friedman

PDF

32388 Demographic and socioeconomic factors drive disparate outcomes in mycosis fungoides, Connor R. Buechler, Ethan Sagher, and Aaron Tisack

PDF

32329 Assessing the utility of Fontana-Masson and MART-1 stains in evaluating skin pigmentary changes induced by ultraviolet radiation and visible light, Marissa Ceresnie, Indermeet Kohli, Ben J. Friedman, Henry W. Lim, and Iltefat H. Hamzavi

PDF

617 The impact of the spectral composition of long-wavelength ultraviolet A1 and visible light on cutaneous biologic effects, Marissa Ceresnie, Jalal Maghfour, K El Dairi, Iltefat H. Hamzavi, Henry W. Lim, and Indermeet Kohli

PDF

542 Murine epidermis harbors functionally distinct langerhans cell subsets, Peter Dimitrion, Indra Adrianto, Yi Yao, Michael Pawlitz, Ian Loveless, and Hongmei Peng

PDF

34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies, Lawrence F. Eichenfield, Linda F. Stein Gold, Zelma C. Chiesa Fuxench, May E. Venturanza, Haobo Ren, and Kanwaljit K. Brar

PDF

275 Effects of ruxolitinib cream on sleep and quality of life over 52 weeks in black patients with atopic dermatitis, L. F. Eichenfield, Linda F. Stein Gold, K. K. Brar, Z. C. Chiesa Fuxench, J. I. Silverberg, M. E. Venturanza, H. Kallender, J. Gao, and E. Simpson

PDF

287 Effects of ruxolitinib cream on pruritus in black patients with atopic dermatitis, L. F. Eichenfield, Linda F. Stein Gold, K. K. Brar, Z. C. Chiesa Fuxench, J. I. Silverberg, M. E. Venturanza, H. Kallender, J. Gao, and J. C. Szepietowski

PDF

367 Googling acne: Analyzing ingredients and price of over the counter acne products, Kareem Elhage, Jonah Yousif, Michael Kwa, and Linda F. Stein Gold

PDF

33714 Palisaded neutrophilic and granulomatous dermatitis in the setting of SRSF2-mutated chronic myelomonocytic leukemia: Case report and review of the literature, Christina D. Enescu, Avni Patel, and Ben J. Friedman

PDF

Updates on the hidradenitis suppurativa from the USA, Iltefat H. Hamzavi

PDF

34612 Exploring the natural history of vitiligo in the United States: Findings from the VALIANT study, John E. Harris, Kristen Bibeau, Iltefat H. Hamzavi, Pearl Grimes, Anouk Lindley, Christine LaFiura, and Khaled Ezzedine

PDF

35224 Identifying a correlation between preceding trauma and development of dermatofibrosarcoma protuberans: A review of the literature, Brittani Jones, Jesse Veenstra, and David M. Ozog

PDF

633 Comparison of soluble proteins from skin sections of acne and TCA induced postinflammatory hyperpigmentation and erythema, N. Karaman-Jurukovska, Iltefat H. Hamzavi, Indermeet Kohli, C. Nicholson, and Tasneem F. Mohammad

PDF

34441 Keratoderma blenorrhagicum and balanitis circinata: Indicators of reactive arthritis, Dayoung Ko, Meredith Hengy, and Chauncey A. McHargue

PDF

623 Variations in in vivo visible light phototesting methodologies, Indermeet Kohli

PDF

35360 Recalcitrant pediatric bullous erythema multiforme responsive to oral tofacitinib, Sasank Konda, Nayha Shetty, and Jesse Y. Liu

PDF

31064 The Detroit Keloid Scale: A validated tool for rating keloids, Alexis B. Lyons, David M. Ozog, Henry W. Lim, Kate V. Viola, Lamont R. Jones, and Amy Tang

PDF

396 Characterizing inpatient hospitalizations for hidradenitis suppurativa and assessing the impact of outpatient dermatology care on hospitalizations, Jalal Maghfour, Vivian Liu, and Richard H. Huggins

PDF

35186 Exploring the association between frontal fibrosing alopecia sunscreen and moisturizers, Jalal Maghfour and Joshua Olson

PDF

33396 Nonuremic calciphylaxis precipitated by COVID 19 infection, Nathaniel Messenger, Christina Artz, and Pranita V. Rambhatla

PDF

33778 The impact and implications of COVID-19 on using scalp cooling therapy for prevention of chemotherapy-induced alopecia, Taylor Novice, Madison Novice, Katerina Svigos, Molly Powers, and Kristen Lo Sicco

PDF

34722 Nail-patella syndrome: An early dermatologic diagnosis, Sandra Oska, Kelly Kennelly, and Vinod Misra

PDF

32622 Imaging technologies for presurgical margin assessment of basal cell carcinoma, Krishan Parashar, Angeli E. Torres, and Wyatt T. Boothby-Shoemaker

PDF

168 COVID-19 mRNA vaccine booster cutaneous reactions reported to the AAD/ILDS dermatology registry, S. Prasad, D. E. McMahon, A. Tyagi, R. Singh, R. Ali, Henry W. Lim, L. P. Fox, K. Blumenthal, G. Hruza, L. E. French, and E. Freeman

PDF

32131 Updating the relative risk of ultraviolet exposure and melanoma in fair skin types: A systematic review, Manisha Ravi, Michael Kwa, Kriti Babu, and Henry W. Lim

PDF

081 Modulation of the aryl hydrocarbon receptor by adipose tissue: Implications for skin carcinogenesis, S. Shareef, Jesse Veenstra, and J. J. Bernard

PDF

35180 “Could I be allergic to my new hidradenitis suppurativa Medication?” Characterization of a cutaneous delayed-type drug hypersensitivity reaction to secukinumab, Nayha Shetty, Sasank Konda, and Jesse Veenstra

PDF

Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: results from two phase III, randomized, double-blinded, placebo-controlled trials, Jonathan I. Silverberg, Diamant Thaçi, Julien Seneschal, Linda F. Stein Gold, Andrew Blauvelt, Eric Simpson, Chia-Yu Chu, Zhuqing T. Liu, Renata Gontijo Lima, Sreekumar Pillai, and Emma Guttman-Yassky

PDF

34587 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by anatomic region: Pooled analysis from two randomized phase 3 studies, Eric L. Simpson, Robert Bissonnette, and Linda F. Stein Gold

PDF

34039 Maintenance of skin clearance in a long-term open-label study of fixed-combination halobetasol propionate and tazarotene lotion for psoriasis in participants with prior use of topical treatments, Linda F. Stein Gold, Javier Alonso-Llamazares, and Joshua Zeichner

PDF

33463 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% by baseline body surface area, Linda F. Stein Gold, Jerry Bagel, James Del Rosso, Lawrence J. Green, Mark Lebwohl, Leon H. Kircik, Amy Feng, Scott Snyder, Robert C. Higham, Patrick Burnett, and David R. Berk

PDF

34613 Tapinarof cream 1% once daily (QD) for plaque psoriasis: Secondary efficacy outcomes from a long-term extension (LTE) trial, Linda F. Stein Gold, Benjamin Ehst, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, Anna M. Tallman, and Jerry Bagel

PDF

33731 Use of digital resource centers for atopic dermatitis patients, caregivers, and health care professionals to improve shared decision-making and proactive management, Linda F. Stein Gold, Adam J. Friedman, and Kanwaljit Brar

PDF

Rapid and clinically meaningful improvement of plaque psoriasis-associated itch after treatment with calcipotriol and betamethasone dipropionate cream, Linda F. Stein Gold, Lawrence J. Green, Sunil Dhawan, Astrid Kirsch, Johan Selmer, and Morten Præstegaard

PDF

32970 Efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: Randomized phase 2 and phase 3 studies of the first triple-combination drug, Linda F. Stein Gold, Leon H. Kircik, and Emil A. Tanghetti

PDF

33354 Efficacy of apremilast in patients with mild to moderate psoriasis assessed by the physician global assessment and body surface area composite tool: Post hoc analysis from ADVANCE, Linda F. Stein Gold, Kim Papp, David Pariser, Howard Sofen, Mindy Chen, Sue Cheng, Hernan Picard, Yuri Klyachkin, and Lawrence Green

PDF

Impact of crisaborole in patients with mild-to-moderate atopic dermatitis who received prior treatment, Linda F. Stein Gold, Vivian Shi, Bonnie Vlahos, Paul Sanders, Chuanbo Zang, and Amy Cha

PDF

33356 A multinational chart review to examine gastrointestinal symptoms and their management in patients treated with apremilast for plaque psoriasis, Linda F. Stein Gold, Edward Tuttle, Wendy Y. Cheng, Rose Chang, Catherine Nguyen, Louise H. Yu, Anne Bouloc, Yuri Klyachkin, Tara Nazareth, and Denis Jullien

PDF

359 Public sunscreen dispenser distribution in the United States: Continued COVID-19 trends during 2021, M. D. Szeto, R. Kokoska, Jalal Maghfour, C. Rundle, C. Presley, T. Harp, A. Hamp, V. Wegener, J. Hugh, and R. Dellavalle

PDF

33111 New onset scrotal lesions in a patient with herpes simplex virus treated with foscarnet, Rebecca F. Wang and Ben J. Friedman

PDF

34745 US and EU sunscreens: A review of ultraviolet (UV) filters and safety data, Nikita Wong, Milan N. Pantelic, and Michael Kwa

PDF

Proactive Management with Cal/BD Foam in Patients with Plaque Psoriasis prolongs Time with improved health-related Quality of Life when compared with reactive Management, Elisabeth Wurzer, Linda F. Stein Gold, Ahmad Jalili, Henrik Thoning, and Piergiacomo Calzavara-Pinton

Submissions from 2021

A case of salivary gland hyalinizing clear cell carcinoma (HCCC) with cutaneous metastasis, Rand Abou Shaar, Sheeren Zia, Mohamed Alhamar, and Ben J. Friedman

Link

A randomized, placebo-controlled, phase 2 study of the Janus Kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa, Afsaneh Alavi, Iltefat Hamzavi, Kurt Brown, Leandro L. Santos, Zhaoyin Zhu, Michael D. Howell, and Joslyn Kirby

PDF

27630 Assessing signs and symptoms of hidradenitis suppurativa from the patient perspective, aFSANEH Alavi, Iltefat H. Hamzavi, Sarah Baradaran, Susan D. Mathias, Hilary H. Colwell, Michael Song, and Chenglong Han

PDF

28353 Hemorrhagic cellulitis secondary to vibrio fluvialis infection, Harleen Arora and Chauncey A. McHargue

PDF

Correlation of PD-L1 expression, clinicopathologic and molecular characteristics in an array of solid tumors: A large-scale real world study, Kanika Arora, Harshita Mehrotra, Kasturi Saikia, Rand Abou Shaar, Mohamed Alhamar, and Dhananjay A. Chitale

Development and validation of facial vitiligo area scoring index (F-VASI) using the fingertip unit, Jung Min Bae, Raheel Zubair, Hyun Jeong Ju, Indermeet Kohli, Han Na Lee, S H. Eun, Alexis B. Lyons, Gautham Vellaichamy, Tae Young Han, Henry W. Lim, and Iltefat Hamzavi

Link

PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa, S Baradaran, S D. Mathias, H H. Colwell, A Alavi, Iltefat H. Hamzavi, M Song, R Villacorta, R Slowik, N Li, and C Han

PDF

26856 Proliferative nodule resembling angiomatoid Spitz with pronounced degenerative atypia arising within a giant congenital nevus, Taylor Braunberger, M Adelman, Tor Shwayder, L E. Clarke, and Ben J. Friedman

PDF

26843 Carbon dioxide laser excision for hidradenitis suppurativa patients—Healing, complications, and recurrence in patients with diabetes mellitus and history of smoking, Taylor Braunberger, P Vakharia, Nneamaka Ezekwe, Cynthia L. Nicholson, Angela Parks-Miller, and Iltefat H. Hamzavi

222 Whole-blood immune profile in hidradenitis suppurativa, Peter Dimitrion, Congcong Yin, Kalpana Subedi, Namir Khalasawi, Yi Yao, Angie Parks-Miller, Jesse Veenstra, Gautham Vellaichamy, Henry W. Lim, Iltefat Hamzavi, Li Zhou, and Qing-Sheng Mi

PDF

28043 Roflumilast cream significantly improves chronic plaque psoriasis in patients with steroid-sensitive area involvement, Zoe Draelos, Mark G. Lebwohl, Charles W. Lynde, Walter K. Nahm, Kim A. Papp, David M. Pariser, Linda F. Stein Gold, Daniel Stewart, Robert C. Higham, Lynn Navale, and David R. Berk

PDF

26085 Key efficacy and safety of apremilast in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial, K C. Duffin, Linda F. Stein Gold, Craig Leonardi, David Pariser, Lawrence Green, Howard Sofen, Bruce Strober, Mindy Chen, Yao Wang, and Kim Papp

PDF

26914 Ustekinumab-induced myositis: A case series, Nneamaka Ezekwe, J Smith, Aunna Pourang, and Iltefat H. Hamzavi

Link

Improvement in patient global impression measures with upadacitinib with or without topical corticosteroids in moderate to severe atopic dermatitis: Results from placebo-controlled phase 3 studies, M Gooderham, M Deleuran, Linda F. Stein Gold, B Calimlim, J Zeng, S Takemoto, E Raymundo, and S Weidinger

LB756 Patient-reported outcomes for sarecycline effectiveness in Acne Vulgaris in real-world settings: PROSES study protocol, E Graber, H Baldwin, J Harper, A Alexis, Linda F. Stein Gold, A Herbert, R Fried, E Rieder, L Kircik, J Del Rosso, I Kasujee, and A Grada

PDF

28666 Global initiatives in dermatology and education, C Grayson, Olabola Awosika, and E Pritchett

Link

25486 Correlation of the Vitiligo Area Scoring Index with patient- and physician-reported measures of clinical improvement in a randomized, double-blind phase 2 study, Iltefat H. Hamzavi, David Rosmarin, Kathleen Butler, Fiona Kuo, Zhaoyin Zhu, and Kang Sun

Link

27099 Actinomyces infection within red pigment of a tattoo, Angela J. Jiang and Holly Kerr

Link

28139 A case of IgA vasculitis associated with underlying cytomegalovirus colitis, Katelyn M. Kim and Ben J. Friedman

Link

28367 A case of chronic prurigo nodularis, angiolymphoid hyperplasia with eosinophilia, and reactive lymphadenopathy: Intersection of multiple processes, or a novel clinical entity?, Elena Kurland, Bridget Myers, Ben J. Friedman, and Pranita V. Rambhatla

LB762 Initiation patterns among novel systemic agents for U.S. adults with Psoriasis and Psoriatic Arthritis, Michael Kwa, R Kang, M Cherupally, C Aikman, and R Ackermann

Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: Results from the open-label run-in period of JADE REGIMEN, Mark G. Lebwohl, Margitta Worm, Linda F. Stein Gold, Christine Bangert, Peter Schmid-Grendelmeier, Tahira Khan, Pinaki Biswas, Marco DiBonaventura, Gary Chan, Ketti Terry, Hernan Valdez, and Claire Clibborn

Link

28545 A man with halo nevi and premature hair graying, Alexis B. Lyons, Olabola Awosika, and Henry W. Lim

Link

27636 Addition of narrow-band ultraviolet light B phototherapy to ruxolitinib cream in patients with vitiligo, Amit G. Pandya, John E. Harris, Mark Lebwohl, Iltefat H. Hamzavi, Kathleen Butler, Fiona Kuo, Shaoceng Wei, and David Rosmarin

Link

25602 Improvements and response achievement in PASI subscale domains for head scaling and erythema in apremilast-treated patients with moderate to severe plaque psoriasis of the scalp: Results from the STYLE study, Kim Papp, Abby Van Voorhees, Linda F. Stein Gold, Mark Lebwohl, Bruce Strober, Zuoshun Zhang, and Yao Wang

Link

26905 The effect of Polypodium leucotomos extract (Fernblock) on visible light and UV-induced photoaging, Aunna Pourang, Mohsen Dourra, Nneamaka Ezekwe, Indermeet Kohli, Iltefat Hamzavi, and Henry W. Lim

PDF

28522 The impact of the SARS-CoV-2 pandemic on phototherapy utilization, Aunna Pourang, Hailey Olds, Nneamaka Ezekwe, Henry W. Lim, and Iltefat H. Hamzavi

Link

28206 Disseminated gonococcal infection manifesting as embolic septic vasculitis, Vignesh Ramachandran and Sasank Konda

Link

28714 Primary cutaneous Fusarium infection in an immunocompetent host, Gabrielle Robinson, Ben J. Friedman, and Chauncey A. McHargue

Link

27568 Maintenance of repigmentation after discontinuation of ruxolitinib cream in patients with vitiligo, David Rosmarin, Amit G. Pandya, Pearl Grimes, Mark Lebwohl, Alice B. Gottlieb, Iltefat H. Hamzavi, Kathleen Butler, Fiona Kuo, Shaoceng Wei, Beth Rumberger, and John E. Harris

Link

27426 A young man with an impressive ulcer on the chest, Ethan Sagher and Anna Axelson

PDF

27874 Correlation of itch response to roflumilast cream with disease severity and patient-reported outcomes in patients with chronic plaque psoriasis, Linda F. Stein Gold, Javier Alonso-Llamazares, Zoe D. Draelos, Melinda J. Gooderham, Steven E. Kempers, Mark G. Lebwohl, Darryl P. Toth, Gil Yosipovitch, Robert C. Higham, Lynn Navale, and David R. Berk

Link

25750 Tapinarof cream 1% once daily for plaque psoriasis: Secondary efficacy outcomes from two pivotal phase 3 trials, Linda F. Stein Gold, Andrew Blauvelt, April Armstrong, Seemal R. Desai, Howard Sofen, Lawrence J. Green, Stephen K. Tyring, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, and Stephen C. Piscitelli

Link

26607 Proactive management using Cal/BD foam in patients with plaque psoriasis prolongs time with a health-related quality of life improvement, compared with reactive management, Linda F. Stein Gold, Ahmad Jalili, Dominique Lons Danic, Nanna Nyholm, Henrik Thoning, and Piergiacomo Calzavara-Pinton

Link

27611 Fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion for the treatment of plaque psoriasis in patients with 3-5% body surface area (BSA) and poor quality of life (QoL), Linda F. Stein Gold, Edward Lain, Jerry Bagel, and Abby Jacobson

Crisaborole ointment, 2%, in patients 3 months of age and older with mild-to-moderate atopic dermatitis (AD), J C. Su, L J. Spelman, L F. Eichenfield, Linda F. Stein Gold, A Cha, D Graham, L Takiya, J L. Werth, C Zang, and B Vlahos

Link

25603 Improvement in scalp psoriasis and quality of life with apremilast in patients with moderate to severe scalp psoriasis regardless of prior systemic treatment: Results from the phase 3, randomized STYLE study, Yao Wang, Linda F. Stein Gold, Mark Lebwohl, Bruce Strober, Zuoshun Zhang, and Abby Van Voorhees

Link

28588 Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study, Matthew Zirwas, Zoe D. Draelos, Janet DuBois, Leon Kircik, Angela Moore, Linda F. Stein Gold, Robert C. Higham, Lynn Navale, Patrick Burnett, and David R. Berk

Submissions from 2020

16392 Efficacy of tapinarof cream by body region in subjects with plaque psoriasis in a phase 2b randomized controlled study, R Bissonnette, Linda F. Stein Gold, L Kircik, S K. Tyring, A Tallman, and A Armstrong

15821 Efficacy and safety of carbon dioxide laser excision in hidradenitis suppurativa: Experience from an urban academic medical center, Taylor Braunberger, P Vakharia, Shanthi Narla, C Nicholson, and Ashley Parks-Miller

LB938 Efficacy of FMX101 4% topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Integrated summary from three phase 3 studies, J Del Rosso, Linda F. Stein Gold, J Weiss, L Green, V Stakias, and I Stuart

16520 Continuing medical education on acne improves dermatologists’ knowledge and competence on patient management, S J. Dermer, J M. Maeglin, and Linda F. Stein Gold

17753 Analysis of 24-week response to ruxolitinib cream for the treatment of vitiligo based on patient demographics and clinical characteristics, Iltefat Hamzavi, J E. Harris, D Rosmarin, P E. Grimes, A Pandya, A B. Gottlieb, K A. Butler, I FI Kuo, K Sun, and M Lebwohl

17955 Comparison of SPF50+ and SPF100+ sunscreens on the induction of cutaneous pigmentation over multiple days: A real-world, single-center, randomized, double-blinded evaluation, Indermeet Kohli, C Nicholson, J D. Williams, I Seo, X Tian, E Atillasoy, Henry W. Lim, and Iltefat H. Hamzavi